UTM Stock Overview
Develops, manufactures, and distributes medical devices for the healthcare industry worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for UTM from our risk checks.
Utah Medical Products, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$64.00 |
52 Week High | US$92.50 |
52 Week Low | US$61.00 |
Beta | 0.15 |
1 Month Change | 1.59% |
3 Month Change | -5.19% |
1 Year Change | -25.15% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 185.52% |
Recent News & Updates
Recent updates
Shareholder Returns
UTM | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0.8% | 0.7% | -0.5% |
1Y | -25.1% | -3.4% | 4.3% |
Return vs Industry: UTM underperformed the German Medical Equipment industry which returned -3.4% over the past year.
Return vs Market: UTM underperformed the German Market which returned 4.3% over the past year.
Price Volatility
UTM volatility | |
---|---|
UTM Average Weekly Movement | 2.9% |
Medical Equipment Industry Average Movement | 4.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.4% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: UTM has not had significant price volatility in the past 3 months.
Volatility Over Time: UTM's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1978 | 180 | Kevin Cornwell | www.utahmed.com |
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies.
Utah Medical Products, Inc. Fundamentals Summary
UTM fundamental statistics | |
---|---|
Market cap | €226.52m |
Earnings (TTM) | €15.08m |
Revenue (TTM) | €45.16m |
14.8x
P/E Ratio5.0x
P/S RatioIs UTM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
UTM income statement (TTM) | |
---|---|
Revenue | US$49.04m |
Cost of Revenue | US$20.08m |
Gross Profit | US$28.96m |
Other Expenses | US$12.58m |
Earnings | US$16.38m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 4.64 |
Gross Margin | 59.05% |
Net Profit Margin | 33.39% |
Debt/Equity Ratio | 0% |
How did UTM perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield26%
Payout RatioDoes UTM pay a reliable dividends?
See UTM dividend history and benchmarksUtah Medical Products dividend dates | |
---|---|
Ex Dividend Date | Jun 14 2024 |
Dividend Pay Date | Jul 05 2024 |
Days until Ex dividend | 24 days |
Days until Dividend pay date | 45 days |
Does UTM pay a reliable dividends?
See UTM dividend history and benchmarks